chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rapid heartbeat; heart rate 103 beats per minute; This is a spontaneous report from a contactable consumer (patient). A 30-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL9264), dose 2 via an unspecified route of administration, administered in upper left arm on 29Jan2021 as single dose for COVID-19 immunization (at the age of 30-year-old). Medical history included infertility female. The patient's concomitant medications were not reported. Patient's historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL3302) via an unspecified route of administration on an unspecified date for COVID-19 immunization (at the age of 30-year-old). Prior vaccination (within 4 weeks) no medication were reported. On an unspecified date in Feb2021, the patient experienced rapid heartbeat; heart rate 103 beats per minute. Patient got vaccinated end of the 29Jan2021, her second dose and then she had been having her rapid heartbeat and issues with that she had been since February this issue, she thought that could be possible side effect. She came across an article and she just got put on Beta blocker (treatment) on Thursday included Atenolol 25 mg and Progesterone because she ended up going to the ER (Emergency Room) because she had heart rate 103 beats per minute and then by the time she went to the ER and it went down little bit but she had to put on IV Metoprolol to get down. Patient was wondering if that side effect of the vaccine or something. She asked that if should tell her provider to kind of health what's going on with her. The patient underwent lab tests and procedures which included heart rate: 103 beats per minute on an unspecified date in Feb2021. The outcome of the event was unknown.  Follow-up attempts are completed. No further information is expected.
pt recvd vax; devel a little red knot,which was raised, & a warm area near the inject site in the thigh;
inappropriate age for vaccine. Janssen not approved for under 18. Pt experienced nausea/vomiting evening of vaccine
Erythema area 9cm x 15cm on extension surface of left upper arm, area is warm to touch and painful rating "8/10"
Patient received his first dose of Pfizer COVID Vaccine (Lot #EW0185, Exp 08/2021) in left deltoid on 05/21/2021 at 11:58 am. Patient states he had been taking penicillin for tonsillitis for approximately 3 days before receiving his first dose of COVID Vaccine. Patient states approximately one hour after receiving his first dose of the Pfizer COVID vaccine, he began to experience "swelling" in his throat. Patient states he was unable to speak for approximately one minute, so he took a drink of water and the swelling immediately relieved. Patient denies SOB. Patient states he lost his voice for two days following this episode. Patient called PCP to report symptom and his doctor advised patient to discontinue use of antibiotics. Patient states he has had an "uncomfortable sore throat" since discontinuing his antibiotics. Patient denies allergies or medical conditions. Patient due to receive dose 2 of Pfizer on 06/11/2021 at . On 06/11/21, patient consulted with nurse about adverse event following his first dose of Pfizer vaccine. Nurse elevated concerns to next upline nurse. Nurse elevated medical consult to doctor. Patient was given medical clearance from doctor at 3:10 pm. Patient received his second dose of the Pfizer COVID vaccine (Lot #ER8735, Exp 08/2021) at 3:11 pm. Nurse provided patient with education related to when to seek medical care, including shortness of breath, chest tightness, and sensation of throat tightness. The patient demonstrates understanding of teaching and states he will call doctor if he experiences these symptoms.
Severe myalgia, chills, fever - flu like symptoms, fatigue, dizziness, joint pain and bilateral  meta-tarsal  pain on hands (which I used to have as part of my osteopenia.  But was symptomless for a while).  After about 18 to 20 hours after vaccination  experienced severe bilateral metatarsal pain and joint pain on knees and back.    Mild to moderate nasal congestion.  Took 1 gram APAP /Benadryl alternating with ASA 325mg  along with bedrest.   Over the course of 2 days the pain (myalgia and arthralgia), flu-like symptoms and congestion resolved.
I received this vaccine when I was 40 weeks and 2 days pregnant (my due date was on the 24th of February. I received the vaccine on the 26th). The symptoms I had included mild fever, body aches and chills, and increased heart rate. My unborn baby also experienced an increased heart rate and this caused me to be induced. My pregnancy up until this point was normal and my baby's heart rate was always in the normal range. Baby was born and weighed 6 lbs. 1 oz.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No information on their medical history, concurrent conditions or concomitant drugs was provided. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX lot# reported as K00884, expiration date 20-SEP-2015 (dose number, site and route of administration not reported). On an unknown date, the patient experienced reaction with burning at injection site and around the injection site, which appeared as though the fat in their arm was being melted. The outcome of the adverse events was unknown. Relatedness between use of ZOSTAVAX and the adverse events was not reported. This is one of several reports from the same reporter. Lot number K00884 is an invalid lot number for ZOSTAVAX. Additional information has been requested.
Headache, Myalgia, injection site pain Narrative: symptoms lasted 48 hours
Slightly sore arm after second dose; This is a spontaneous report from a contactable consumer (patient). A 71-years-old female patient (non-pregnant) received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: EL9264 ) dose 2 via an unspecified route of administration, administered in left arm on 17Feb2021 at 02:00 PM (at the age of 71-years-old) as DOSE 2, SINGLE for covid-19 immunisation. The patient was not pregnant at the time of vaccination. Medical history included High blood pressure, High Cholesterol, Hypothyroid, Known allergies to sulfa and bees. Concomitant medication(s) included LEVOTHYROXINE, SANCTURA, PRAVASTATIN, BUSPAR, and ATENOLOL. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient was not tested for COVID-19. The patient previously took Tramadol, Celebrex, Theophylline, and experienced known allergies to Tramadol, Celebrex, Theophylline. The patient previously took bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: unknown) dose 1 via an unspecified route of administration, administered in left arm on 28Jan2021 at 01:00 pm in hospital for (at the age of 71-years-old) Covid-19 immunisation and experienced very slight chills lasting 2 hours evening after first dose. The patient experienced slightly sore arm after second dose (on an unspecified date in Feb2021) but took Tylenol immediately after shot. Therapeutic measures were taken as a result of event occurred taken Tylenol immediately after shot. Outcome of the event was unknown.  Follow-up attempts are completed. No further information is expected.
patient was unresponsive and dazed approximately 8 minutes post pfizer booster vaccine
Information has been received from a certified medical assistant (C.M.A.) concerning a female patient age 11-12 years old who "in the last 5 months" (in 2007) was vaccinated with Gardasil vaccine. Subsequently, "in the last 5 months" (in 2007) the patient passed out within a moment of being vaccinated. Medical attention was sought, in the office. She was treated with cool compresses and rest and her blood pressure was monitored. Subsequently, the patient recovered. She will continue with the vaccination series as scheduled. This is one of four total reports received from the same source. One of the girls received the third dose of Gardasil vaccine and Havrix. The other girls were receiving the first dose of Gardasil vaccine. The reporter did not specify which of the four patients was receiving the third dose. Additional information has been requested.
Redness measured 2" diameter around injection site. No fever, pain or temp. Went away in a couple days. No other symptoms.
Contacted pharmacy next morning to state (R) arm was very sore, swollen, red. He took TYLENOL #3 for pain (helped). Area was swollen/red/sore under armpit (not deltoid).
pt recv 1 dose of varivax on 7/96 & on 4/98 pt devel chickenpox consisting of pustular lesions
injection site is hot and red; Neck pain; arm started to itch bad (All this is occurring on the injection site); pain from her shoulder to her neck/Join pain/pain all the way down from elbow to fingers; knots in her arm (All this is occurring on the injection site)/upper arm looks like it could be her calf/that is how swollen it is; injection site is hot and red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (injection site is hot and red), NECK PAIN (Neck pain), VACCINATION SITE PRURITUS (arm started to itch bad (All this is occurring on the injection site)), ARTHRALGIA (pain from her shoulder to her neck/Join pain/pain all the way down from elbow to fingers) and VACCINATION SITE SWELLING (knots in her arm (All this is occurring on the injection site)/upper arm looks like it could be her calf/that is how swollen it is) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022MQ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Allergic to NSAIDs), Drug allergy (Allergic to aspirin), Drug allergy (Allergic to benadryl) and Drug allergy (Allergic to antihistamines).    On 10-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jul-2021, the patient experienced VACCINATION SITE WARMTH (injection site is hot and red), NECK PAIN (Neck pain), VACCINATION SITE PRURITUS (arm started to itch bad (All this is occurring on the injection site)), ARTHRALGIA (pain from her shoulder to her neck/Join pain/pain all the way down from elbow to fingers), VACCINATION SITE SWELLING (knots in her arm (All this is occurring on the injection site)/upper arm looks like it could be her calf/that is how swollen it is) and VACCINATION SITE ERYTHEMA (injection site is hot and red). At the time of the report, VACCINATION SITE WARMTH (injection site is hot and red), NECK PAIN (Neck pain), VACCINATION SITE PRURITUS (arm started to itch bad (All this is occurring on the injection site)), ARTHRALGIA (pain from her shoulder to her neck/Join pain/pain all the way down from elbow to fingers), VACCINATION SITE SWELLING (knots in her arm (All this is occurring on the injection site)/upper arm looks like it could be her calf/that is how swollen it is) and VACCINATION SITE ERYTHEMA (injection site is hot and red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication reported included xolost 100 mg once daily. Patient was prescribed steroids for treatment.
This spontaneous report as received from a other health professional refers to a patient of unknown age, gender, ethnicity. Previous medical history were not reported. On 29-OCT-2013 the patient was vaccinated with GARDASIL dose 1, 1 DF, intramuscular (lot number was not provided). On 29-OCT-2013, 1 day after onset of therapy the patient experienced received first dose on 10/29/2013 and second dose on 02/11/2014 and the third dose being given on 12/03/2014 and no adverse event. The outcome of received first dose on 10/29/2013 and second dose on 02/11/2014 and the third dose being given on 12/03/2014 and no adverse event is unknown. Action taken with therapy drug was not reported. The reporter considered received first dose on 10/29/2013 and second dose on 02/11/2014 and the third dose being given on 12/03/2014 and no adverse event to be not related to GARDASIL. No further information were provided.
Shortly p/receiving a dose of Td, pt exp edema, redness, & soreness @ inject site;
Right after flu shot given, immediate local swelling just at injection site occurred (right upper arm). The area was a soft swelling and became about as big as a golf ball (no bleeding at all). Pt was in no distress or discomfort. Ice pack applied. Pt was called this AM to see how he was doing and he states it is resolved and had no further problem.
I have been dizzy and have very sensitive ears since the second day after my booster shot on 12/20. I have been taking Ibuprofen for headaches.
Patient was given Pfizer bivalent booster for >12 year olds and he is 11 years old.  Parent was advised and states no concerns.  Will watch for any reaction and will contact the clinic.
HJeart rate 150, BP 80/60, T-99.2 degrees F @ 1140 am. skin very warm to touch and dry. skin red like a sunburn on arms, shoulders, back, legs and cheeks. 1212 pm T-96.7 degrees F, pulse 120. Decrease in red, warm skin
Patient developed a rash on both arms at 11:55am about 15 minutes after her shot. Patients blood pressure was taken (158/82) and was given 50mg of Benadryl orally. Patient was checked on at 12:15am and she was feeling ok. Patient's blood pressure was taken again at 12:25pm (157/89). Patient was checked on again at 12:45pm and she was feeling fine. Patient felt that her symptoms were gone and wanted to leave at 12:56pm.  Patient was counseled to continue Benadryl if symptoms persist and to call emergency services if she began to worsen.
Patient received injection right arm. Later that day he played racquet ball and injured his right hand and arm. Next day right arm was swollen and tender. Saw MD within 48 hours. Swelling confined to forearm. Started ATB. Resolved by 2/8.
Oct 7 received flu shot and woke the next morning unable to lift arm due to pain and "just couldn't get muscle to work." Very painful for the next couple of weeks.  Went to doctor on Oct 22 and he directed her to physical therapy- no tissue damage noted.  Is a little better but still has and ROM and difficult to move arm.
No additional AEs; ROTATEQ administered after a temperature excursion; This spontaneous report was received from office manager and referred to a patient of unknown age and gender. Concomitant medication, pertinent medical history and drug reactions/allergies were not applicable.  On 14-APR-2022, the patient was vaccinated with the improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (lot #1742463, expiration date: 20-SEP-2022) orally for prophylaxis (strength, and dose were not provided) (product storage error).  It was reported that the suspect vaccine was exposed to a temperature of 55 Fahrenheit (F) for a time frame of 1 hours. There were no previous temperature excursions.   No other adverse event (AE) occurred.
Information has been received from a registered nurse referring to unspecified patients of unknown age and gender. The patients' concurrent and historical conditions were not reported. Since 13-JAN-2016 doses of VARIVAX (Merck) (lot # L024250, expiration date 30-JUN-2017; lot # L027287, expiration date 21-JUL-2017), which were exposed to temperature outside of the recommended range (at -12.1 centigrade for 15 to 30 minutes) on 13-JAN-2016, had been administered (dose and route were unknown) to unspecified patients (Incorrect product storage). There were no temperature excursion issues previously. Concomitant therapies were not reported. No adverse experience was reported. This is one of the several reports received from the same reporter. Additional information has been requested.
I had no adverse effect from either of my first two Moderna vaccines.  This adverse event came after my Moderna booster.  I was walking early in the morning the day after my booster as I usually do.  I was on my way home and fainted.  I phoned for someone to come pick me up.  Once home I fainted 2 more times. I felt very tired and lethargic for two additional days.  Due to the fainting I have most likely broken my coccyx.
Pt reported immediate chest pain. This was followed by headache, persisting chest pain and heavines/pain/weakness in b/l arms. Normal CXR/EKG Sx persisted x 2 w. steroids ordered 1 d ago.
Approximately 6 hours after vaccination, we noticed inflammation in his left thigh. Waking up the next day (Friday), the inflammation had increased and he was walking a noticeable limp. After brief consult with Pediatrician, we provided pain reliever and gentle massage along with warm compress which did not improve nor worsen symptoms. Day 3 was similar, and by day 4, the swelling starting to subside and his walking is no longer impeded by a limp. Day 5, the swelling appeared to be down to normal.
h/o HTN Gout , CKD, GSW with retained fragments  Received the MOderna injection on 6/15 and within 1/2 hour of the shot he states developed the "lost of sight " then vomiting. Since then he has noted moderate diarrhea with some bloody stools for the past week.  Reports he initially lost his eyesight after vaccine for 2 minutes when he left the doctor's clinic. Vomited when he got home and had diarrhea x 1 wk. Noticed "knots" on his arms. He was evaluated on 6/22, given methylprednisolone injection; then prednisone taper. Later he developed rectal bleeding which prompted him to the ER on 6/27/21.
FEVER; NAUSEA; HEADACHE; HEART WAS RACING; TROUBLE SLEEPING; BODY HURTING; BACK HURTING; LIGHTHEADEDNESS; SORE ARM; This spontaneous report received from a patient concerned a 60 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805020 expiry: UNKNOWN) dose was not reported, administered on 19-MAR-2021 at 10:00 on left arm for prophylactic vaccination . No concomitant medications were reported. On 19-MAR-2021, the subject experienced heart was racing. On 19-MAR-2021, the subject experienced trouble sleeping. On 19-MAR-2021, the subject experienced body hurting. On 19-MAR-2021, the subject experienced back hurting. On 19-MAR-2021, the subject experienced lightheadedness. On 19-MAR-2021, the subject experienced sore arm. On 19-MAR-2021 at 22:00, the subject experienced fever. On 19-MAR-2021, the subject experienced nausea. On 19-MAR-2021, the subject experienced headache. Laboratory data included: Body temperature (NR: not provided) 102 F. Treatment medications included: paracetamol. On 20-MAR-2021 01:00, treatment medications included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from heart was racing, and trouble sleeping on 21-MAR-2021, and nausea, was recovering from body hurting, and back hurting, and had not recovered from sore arm, fever, headache, and lightheadedness. This report was non-serious.
DTR BECAME DIZZY AND LIGHTHEADED. I INSTRUCTED MY DTR TO LAY DOWN,  WITHIN SECONDS SHE STARTED TO SHAKE AND WAS UNRESPONSIVE. I SCREAMED  FOR HELP DR, NURSE AND MA CAME IN WITHIN SECONDS.
Donor complained of slight tolerable headache on the day after receiving tetanus injection as become less in severity.  Advised donor to see MD if headache does not resolve.  No complaints of soreness at injection site or fever.
I am currently experiencing vertigo, nausea, dizziness to a degree that effects my ability to do work or concentrate. I also had an adverse reaction  from 5-11-21 to 5-15-21 with chills, fever, fatigue, body aches.
Per PA-C notes on 3/5/2021: Patient received Pfizer vaccination. After about 10 minutes patient noted generalized pruritis and erythema at injection site. Patient denied any other symptoms. He denies breathing difficulty. Allergy, medicine list and PMH has reviewed. Patient reported tolerating Benadryl prior. 50 IM Benadryl was ordered and administered via nurse.
Notes: EE with sore throat on 12/21, left work early and was tested, resulted (+).  EE states her symptoms are resolved.  In quarantine ending 12/31, released on 1/1/22 if still asymptomatic.
The patient informed us that she felt fine while she was in the store. When she left the store she fell in the parking lot, hit her head and scraped her arm.  She said she felt "funny" for a few days after this.
Information has been received from a nurse practitioner concerning a 60 day old female patient who on 11-MAY-2009 was vaccinated orally with the first dose of ROTATEQ (Lot # 663265/1585X). On 14-JUL-2009 the patient was vaccinated orally with the second dose of ROTATEQ (Lot # 663461/0285Y). On 14-SEP-2009 the patient was vaccinated orally with the third dose of ROTATEQ (Lot #663848/0147Y) and regurgitated it 1-2 minutes later. The patient received a partial 4th dose of ROTATEQ (Lot # 663848/0147Y) on 14-SEP-2009. The patient started gagging so the full 4th dose was not given. The nurse practitioner mentioned the patient gagged after receiving the first and second dose but did not vomit the doses. The patient had sought medical attention, in the office. At the time of the report the patient's status was recovered. Follow-up information has been received from a physician indicated that the female patient with no illness at time of vaccination and with no pre-existing allergies, birth defects and medical conditions who was vaccinated with the third dose of ROTATEQ (Lot # 663848/0147Y) orally on 14-SEP-2009 at the age of 26 weeks old. The patient also was vaccinated with third dose of PENTACEL (Lot# C3362AA) in the left anterior lateral thigh on 14-SEP-2009 and the third dose of PREVNAR (Lot # 181705) in the right anterior lateral thigh on 14-SEP-2009. On 14-SEP-2009 at 10:00am the child gagged an unnoted dose of ROTATEQ. There were attempts to repeat dose to the child and the child gagged and spit out vaccine again. There were no respiratory problems and no distress. The patient had not sought medical attention. There were no relevant diagnostic tests. At the time of report the patient's status was recovered. Follow-up information has been received from a physician indicated that the female patient with no illness at time of vaccination and with no pre-existing allergies, birth defects and medical conditions who was vaccinated with third dose of ROTATEQ (lot# 663848/0147Y) orally on 14-Sep-2009 at 10:30 am. The patient also was vaccinated with the third dose of PENTACEL (Lot# C3362AA) IM in the left anterior lateral thigh on 14-SEP-2009 and the third dose of PREVNAR (Lot# D181705) IM in the right anterior lateral thigh on 14-SEP-2009. On 14-SEP-2009 at 10:30 am after ROTATEQ was given the patient immediately vomited. There were attempts to repeat dose to the child and the child vomited and spit out vaccine again. The patient had not sought medical attention. There were no relevant diagnostic tests. At the time of report the patient's status was recovered. Additional information is not expected.
This spontaneous report as received from a consumer refers to his 67 year old wife with no pertinent medical history, drug reactions or allergies. On 02-DEC-2013 (also reported as 4 weeks ago), the patient was vaccinated with ZOSTAVAX, intramuscular (dose, strength and lot number were not reported). There was no concomitant medications. On 02-DEC-2013, the patient was concerned about the efficacy of the vaccine, since she was sure that the shot was given to her intramuscularly. The consumer reported that his wife experienced itching at the injection site, later in the evening after getting the shot and the itching continued for the next couple of days. The itching has since subsided. On 04-DEC-2013, two days after getting the shot the patient recovered from the events. The patient did not received treatment for the adverse events. The patient did not seek medical attention. No diagnostics studies were performed. Additional information has been requested.